missing translation for 'onlineSavingsMsg'
Learn More

ASTX660, MedChemExpress

Product Code. 16493026
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
25 mg
Unit Size:
10mg
25mg
5mg
This item is not returnable. View return policy

Product Code. 16493026

Brand: Medchem Express HY109565

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress ASTX660 is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP).

ASTX660 is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP).

Specifications

Chemical Name or Material ASTX660
CAS 1799328-86-1
Color Off-White
Purity Grade Notes Research
Molecular Formula C30H42FN5O3
Quantity 25 mg
Solubility Information DMSO : 100 mg/mL (185.29 mM; Need ultrasonic)
SMILES C[C@H]1N(C[C@@H]2N(CC(N3CC(C)(C)C4=NC(CO)=C(CC5=CC=C(F)C=C5)C=C43)=O)C[C@@H](C)NC2)CCOC1
Molecular Weight (g/mol) 539.68
Formula Weight 539.68
Percent Purity 98.99%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.